US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

23.07

+0.07000.30%

Post-market: 23.120.0550+0.24%16:10 EDT

Volume:2K

Turnover:56.63K

Market Cap:4.61M

PE:- -

High:23.28

Open:23.00

Low:23.00

Close:23.00

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:15.02

T/O Rate:1.23%

Dividend:0.08

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Calidi receives pre-IND regulatory feedback from FDA for CLD-401

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial

XBiotech to enroll patients in vilamakitug trial following FDA review

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

HBM Holdings (SEHK:2142) Stock Valuation After New IND Milestone For Cancer Antibody HBM7004

Simply Wall St.

Shanghai Bao Pharma Wins U.S. FDA IND Clearance for First Subcutaneous Ceftriaxone Candidate

HBM Wins China IND Nod for Bispecific Cancer Antibody HBM7004

Antengene Secures China IND Approval for Autoimmune Disease Drug

MT Newswires Live

Antengene Wins China IND Nod for ATG-201 Autoimmune Trial

ANTENGENE-B Receives Chinese IND Approval for ATG-201 in Autoimmune Disease Treatment

Antelopus Selan Energy Secures IND A/Stable and IND A1 Ratings for INR 3,000 Million Loan Facilities

India Ratings Affirms RSWM at IND A, Revises Outlook to Stable

Modi's Third Term: India's Economic Growth Story Faces Its Most Severe Test Yet

Haisco Pharmaceutical Receives IND Application Acceptance for Novel Pain Drug HSK51155

Chery Clarifies Nature of Partnership with Tata Group, Confirms No Direct Investment or Tech Transfer in India

World Gold Council Analyzes Impact of India's Tightened Gold Import Policies

USD/INR Holds High Amidst Fed Rate Hike Fears and Oil Price Surge

India's Central Bank Holds Rates, Unveils Measures to Support Rupee Amid Depreciation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IND/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":23.065,"timestamp":1787601600000,"preClose":22.995,"halted":0,"volume":2451,"hourTrading":{"tag":"盘后","latestPrice":23.12,"preClose":23.065,"latestTime":"16:10 EDT","volume":7,"amount":161.455,"timestamp":1787602204726,"change":0.055,"changeRate":0.002385,"amplitude":0},"delay":0,"changeRate":0.0030441400304414127,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Closed","change":0.07,"latestTime":"08-24 16:00:00 EDT","open":23,"high":23.28,"low":23,"amount":56631,"amplitude":0.012177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":22.995,"sharesOutstanding":200001,"nav":23.031,"aum":4606217.85,"dividendRate":0.003408,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":23.1,"preClose":22.995,"latestTime":"09:29 EDT","volume":206,"amount":4758.869860000001,"timestamp":1787578199043,"change":0.105,"changeRate":0.004566,"amplitude":0.004784},"postHourTrading":{"tag":"盘后","latestPrice":23.12,"preClose":23.065,"latestTime":"16:10 EDT","volume":7,"amount":161.455,"timestamp":1787602204726,"change":0.055,"changeRate":0.002385,"amplitude":0},"volumeRatio":15.018366},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":15.018366,"shares":200001,"dividePrice":0.0786,"high":23.28,"amplitude":0.012177,"preClose":22.995,"low":23,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":23.065,"eps":0,"divideRate":0.003408,"volume":2451,"delay":0,"ttmEps":0,"open":23,"prevYearClose":24.78,"prevWeekClose":22.995,"prevMonthClose":22.885,"prevQuarterClose":22.88,"fiveDayClose":23.005,"twentyDayClose":22.495,"sixtyDayClose":22.475},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643757846","title":"Calidi receives pre-IND regulatory feedback from FDA for CLD-401","url":"https://stock-news.laohu8.com/highlight/detail?id=2643757846","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643757846?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:39","pubTimestamp":1781613560,"startTime":"0","endTime":"0","summary":"Calidi (CLDI) announced that it has received pre-IND regulatory feedback from the FDA providing alignment and clarity on Calidi’s IND-enabling prec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calidi-receives-pre-ind-regulatory-feedback-from-fda-for-cld-401-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calidi-receives-pre-ind-regulatory-feedback-from-fda-for-cld-401-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IND","BK4139","CLDI","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643875208","title":"Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643875208","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643875208?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:33","pubTimestamp":1781613180,"startTime":"0","endTime":"0","summary":"EB612, a first-in-class long-acting PTH(1-34) oral peptide for hypoparathyroidism, produced robust bioavailability and sustained increases in calcium across three preclinical models; IND is expected i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3312598/0/en/Entera-Reports-Robust-Preclinical-Data-for-EB612-Oral-LA-PTH-1-34-for-Hypoparathyroidism-and-EB618-Oral-GLP-1-Glucagon-for-Obesity-at-ENDO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4183","GLP","ENDO","IND","BK4202","PTH","BK4139","BK4144","ENTX","BK4590","OPK","OXM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643975276","title":"Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2643975276","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643975276?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:00","pubTimestamp":1781611200,"startTime":"0","endTime":"0","summary":"IND enabling studies with CLD-401 to continue with IND submission targeted by end of 2026 as Calidi continues to explore regulatory filing for CLD-401 in Australia in parallelSAN DIEGO, June  16, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3312482/0/en/Calidi-Biotherapeutics-Receives-Positive-Pre-IND-Feedback-from-US-FDA-for-CLD-401-Indicating-Agreement-on-its-Current-Development-Strategy-as-it-Advances-Towards-a-First-in-Human-S.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IND","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643517217","title":"Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643517217","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643517217?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:32","pubTimestamp":1781609520,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, June  16, 2026  (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3312463/0/en/Clearmind-Medicine-Completes-Dosing-for-Part-A-of-its-of-FDA-Regulated-Phase-I-II-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643508209","title":"XBiotech to enroll patients in vilamakitug trial following FDA review","url":"https://stock-news.laohu8.com/highlight/detail?id=2643508209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643508209?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:21","pubTimestamp":1781529699,"startTime":"0","endTime":"0","summary":"XBiotech (XBIT) announced that its investigational new drug, or IND, application for V-SPINE, a Phase II, double-blind, placebo-controlled, randomi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xbiotech-to-enroll-patients-in-vilamakitug-trial-following-fda-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xbiotech-to-enroll-patients-in-vilamakitug-trial-following-fda-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","IND","BK4139","XBIT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643206760","title":"XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206760","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643206760?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:00","pubTimestamp":1781528400,"startTime":"0","endTime":"0","summary":"IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path for U.S. Patient Enrollment AUSTIN, Texas, June  15, 2026  (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/15/3311812/35550/en/XBiotech-Launches-Phase-II-Clinical-Trial-Evaluating-Vilamakitug-for-the-Treatment-of-Active-Axial-Spondyloarthritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU1668664300.SGD","LU2417539215.USD","LU0477156953.USD","LU1267930227.SGD","LU0203345920.USD","LU0980610538.SGD","LU1366192091.USD","LU0320765646.SGD","BK4566","BK4534","LU0130102774.USD","LU0314106906.USD","LU2236285917.USD","LU0098860793.USD","IND","LU2462157665.USD","LU2360032135.SGD","BK4139","LU1244550221.USD","LU2125154778.USD","LU0648001328.SGD","LU1201861249.SGD","LU1244550577.SGD","LU0130517989.USD","LU0310800965.SGD","LU0128525689.USD","LU2125154935.USD","BK4559","BK4207","LU1506573853.SGD","LU2456880835.USD","LU0170899867.USD","LU1162221912.USD","BK4585","BK4588","BK4504","IE00BSNM7G36.USD","LU1244550494.USD","CUL3","XBIT","LU0052756011.USD","LU1791807156.HKD","LU0072461881.USD","LU0106831901.USD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643219713","title":"HBM Holdings (SEHK:2142) Stock Valuation After New IND Milestone For Cancer Antibody HBM7004","url":"https://stock-news.laohu8.com/highlight/detail?id=2643219713","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643219713?lang=en_us&edition=fundamental","pubTime":"2026-06-13 11:28","pubTimestamp":1781321337,"startTime":"0","endTime":"0","summary":"HBM Holdings (SEHK:2142) is back in focus after China’s National Medical Products Administration accepted its investigational new drug filing for HBM7004, a bispecific antibody for advanced solid tumors, following earlier U.S. FDA clearance.\nSee our latest analysis for HBM Holdings.\nDespite the positive regulatory news, the stock’s recent momentum has cooled, with a 30 day share price return down 21.58% and the year to date share price return down 16.97%. This comes even as the 1 year total...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-stock-valuation-after-new-ind-mileston","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-stock-valuation-after-new-ind-mileston","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1574","HBM","BK1161","DRAM","BK4168","IND","BK1583","BK4588","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642625428","title":"Shanghai Bao Pharma Wins U.S. FDA IND Clearance for First Subcutaneous Ceftriaxone Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2642625428","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642625428?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:01","pubTimestamp":1781089264,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co Ltd Class H ( ($HK:2659) ) has shared an update. Shanghai Bao Pharmaceuticals has secured U.S. FDA approval of an i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/shanghai-bao-pharma-wins-u-s-fda-ind-clearance-for-first-subcutaneous-ceftriaxone-candidate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/shanghai-bao-pharma-wins-u-s-fda-ind-clearance-for-first-subcutaneous-ceftriaxone-candidate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","IND","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642848417","title":"HBM Wins China IND Nod for Bispecific Cancer Antibody HBM7004","url":"https://stock-news.laohu8.com/highlight/detail?id=2642848417","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642848417?lang=en_us&edition=fundamental","pubTime":"2026-06-10 12:37","pubTimestamp":1781066249,"startTime":"0","endTime":"0","summary":"HBM Holdings Ltd. ( ($HK:2142) ) has issued an announcement. HBM Holdings Ltd. announced that China’s National Medical Products Administration has ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hbm-wins-china-ind-nod-for-bispecific-cancer-antibody-hbm7004?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hbm-wins-china-ind-nod-for-bispecific-cancer-antibody-hbm7004?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRAM","IND","BK4168","BK4588","HBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642415735","title":"Antengene Secures China IND Approval for Autoimmune Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2642415735","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642415735?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:31","pubTimestamp":1781051482,"startTime":"0","endTime":"0","summary":"Antengene (HKG:6996) said China's National Medical Products Administration has approved an Investigational New Drug (IND) application for a Phase I study of ATG-201, according to a voluntary filing on","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","BK1583","BK1574","BK1191","IND","IND.AU","06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642241315","title":"Antengene Wins China IND Nod for ATG-201 Autoimmune Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642241315","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642241315?lang=en_us&edition=fundamental","pubTime":"2026-06-10 07:10","pubTimestamp":1781046659,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Antengene Corporation Limited ( ($HK:6996) ). Antengene has secured approval from China’s National Medical Prod...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/antengene-wins-china-ind-nod-for-atg-201-autoimmune-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/antengene-wins-china-ind-nod-for-atg-201-autoimmune-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192694235","title":"ANTENGENE-B Receives Chinese IND Approval for ATG-201 in Autoimmune Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1192694235","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192694235?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:24","pubTimestamp":1781043854,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration has granted approval for the Investigational New Drug application for a Phase I study of ATG-201.ATG-201 is a CD19/CD3 bispecific T-cell engager...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996","IND","BK1583","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642494911","title":"Antelopus Selan Energy Secures IND A/Stable and IND A1 Ratings for INR 3,000 Million Loan Facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2642494911","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642494911?lang=en_us&edition=fundamental","pubTime":"2026-06-10 02:26","pubTimestamp":1781029589,"startTime":"0","endTime":"0","summary":"Selan Exploration Technology Limited ( ($IN:ANTELOPUS) ) has provided an update. Antelopus Selan Energy Limited has received new credit ratings fro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/antelopus-selan-energy-secures-ind-a-stable-and-ind-a1-ratings-for-inr-3000-million-loan-facilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/antelopus-selan-energy-secures-ind-a-stable-and-ind-a1-ratings-for-inr-3000-million-loan-facilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642049581","title":"India Ratings Affirms RSWM at IND A, Revises Outlook to Stable","url":"https://stock-news.laohu8.com/highlight/detail?id=2642049581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642049581?lang=en_us&edition=fundamental","pubTime":"2026-06-09 22:14","pubTimestamp":1781014440,"startTime":"0","endTime":"0","summary":"An announcement from RSWM Ltd ( ($IN:RSWM) ) is now available. RSWM Ltd has announced that India Ratings & Research has affirmed the company’s issu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-affirms-rswm-at-ind-a-revises-outlook-to-stable?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-affirms-rswm-at-ind-a-revises-outlook-to-stable?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNDmain","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159294168","title":"Modi's Third Term: India's Economic Growth Story Faces Its Most Severe Test Yet","url":"https://stock-news.laohu8.com/highlight/detail?id=1159294168","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159294168?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:11","pubTimestamp":1780999916,"startTime":"0","endTime":"0","summary":"Overseas securities investment institutions have sold a cumulative $29.5 billion worth of Indian equities so far this year, compared to nearly $19 billion for the entirety of last year.Experts note...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVP","BK4585","NDIA","INDA","SCIN","INCO","BK4523","INDE","IND","NFTY","PIN","BK4588","INQQ","INDL","EPI","GLIN","INDY","FLIN","SMIN","EMXC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110254662","title":"Haisco Pharmaceutical Receives IND Application Acceptance for Novel Pain Drug HSK51155","url":"https://stock-news.laohu8.com/highlight/detail?id=1110254662","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110254662?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:28","pubTimestamp":1780993720,"startTime":"0","endTime":"0","summary":"Haisco Pharmaceutical Group Co.,Ltd. (002653.SZ) has announced the receipt of an acceptance notice from the National Medical Products Administration for its Investigational New Drug (IND) application...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","BK1574","06978","BK0077","BK0188","002653","BK0239","BK0028","BK0033","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172188048","title":"Chery Clarifies Nature of Partnership with Tata Group, Confirms No Direct Investment or Tech Transfer in India","url":"https://stock-news.laohu8.com/highlight/detail?id=1172188048","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172188048?lang=en_us&edition=fundamental","pubTime":"2026-06-08 17:20","pubTimestamp":1780910432,"startTime":"0","endTime":"0","summary":"Chery Automobile has issued a statement clarifying the nature of its ongoing discussions with India's Tata Group. The company stated that the potential cooperation agreement under negotiation is...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDL","INDY","INCO","GLIN","INDA","BK4588","INQQ","EPI","SCIN","INDE","BK4585","BK4523","IND","NDIA","NFTY","PIN","SMIN","FLIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175018616","title":"World Gold Council Analyzes Impact of India's Tightened Gold Import Policies","url":"https://stock-news.laohu8.com/highlight/detail?id=1175018616","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175018616?lang=en_us&edition=fundamental","pubTime":"2026-06-08 15:41","pubTimestamp":1780904501,"startTime":"0","endTime":"0","summary":"The Indian market has implemented a significant tightening of gold import policies. In May, India's gold import duty was sharply increased by 9 percentage points, rising from 6% to 15%, marking the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHNY","GBUG","GDX","GLDY","GLD","GOAU","FLIN","UGL","BEGS","PHYS","PIN","GOLY","BAR","SGCmain","SGUmain","RING","AAAU","EPI","PICK","BK4504","KGLD","GLIN","SGOL","USG","GCmain","DGP","DUST","UYM","BK4523","BK4585","BTGD","518880","SCIN","CEF","INDA","IAUI","IAU","OUNZ","DGZ","JDST","159831","GLL","BGLD","GDXD","GLDM","GLTR","INCO","1OZmain","NDIA","INDY","DBC","GDXJ","GDXU","QOmain","IGLD","DULL","INDL","PALL","NUGT","NFTY","GDXY","159934","MGCmain","INDE","SMIN","JNUG","DZZ","BK4535","IAUM","FGDL","BK4588","XME","IND","INQQ","SGDM","YGLD","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164656018","title":"USD/INR Holds High Amidst Fed Rate Hike Fears and Oil Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1164656018","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164656018?lang=en_us&edition=fundamental","pubTime":"2026-06-08 15:22","pubTimestamp":1780903349,"startTime":"0","endTime":"0","summary":"The US dollar to Indian rupee pair continued its rebound during Monday's Asian trading session, with the exchange rate climbing near 95.60. A strong US dollar, rising international oil prices, and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIN","US30Y.BOND","BK4523","TLTW","INDA","NFTY","INQQ","NDIA","EPI","BK4585","US6M.BOND","INDE","GLIN","IMVP","IND","TLT","BK4588","US12M.BOND","SMIN","INDY","US2Y.BOND","US10Y.BOND","INDL","SCIN","FLIN","TMF","US5Y.BOND","INCO","US7Y.BOND","US3Y.BOND","IUmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130759338","title":"India's Central Bank Holds Rates, Unveils Measures to Support Rupee Amid Depreciation","url":"https://stock-news.laohu8.com/highlight/detail?id=1130759338","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130759338?lang=en_us&edition=fundamental","pubTime":"2026-06-05 15:40","pubTimestamp":1780645246,"startTime":"0","endTime":"0","summary":"India's central bank has introduced a series of measures to support the local currency after the rupee fell to a record low, while keeping its benchmark interest rate unchanged to underpin the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDIA","FLIN","INDY","BK4523","INDE","SCIN","INQQ","SMIN","NFTY","INCO","IMVP","BK4585","BK4588","IND","INDA","EPI","INDL","PIN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}